Mindfulness-based intervention is helpful to younger breast cancer survivors
the ONA take:
Researchers from the University of California in Los Angeles randomized younger women (50 years and younger) with early stage breast cancer who had completed cancer treatment to a 6-week Mindful Awareness Practices (MAPS) intervention group or to a wait-list control group.
Outcomes were assessed via questionnaires participants completed before and after the intervention. The results demonstrated that the MAPS intervention led to reductions in perceived stress, depressive symptoms, proinflammatory gene expression, and inflammatory signaling.
Improvements were also seen in secondary outcomes related to fatigue, sleep disturbance, and vasomotor symptoms.
However, the 3-month follow-up assessment revealed the effects on psychological and behavioral measures were not maintained. The authors conclude that brief, mindfulness-based intervention has short-term efficacy for younger breast cancer survivors.
Younger women with early stage breast cancer who had completed cancer treatment to a 6-week MAPS.
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- G-CSF May Help Preserve Fertility in Male Patients With Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Patients With HER2-enriched Subtype Benefit Most from Dual HER2 Blockade
- Scalp Cooling Reduces Risk of Chemotherapy-Induced Alopecia
- CRISPR Illustrates Progression of Normal Blood Cells to Leukemia, Precursor Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|